Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gadolinium-Based Contrast Agents (GBCAs) - Protein Binding (GBCA Protein Binding)
- Target
- GBCA Protein Binding
- Molecular classification
- Contrast Agent Property, Drug-Protein Interaction
01
Overview
The protein binding properties of gadolinium-based contrast agents (GBCAs) significantly influence their behavior in the bloodstream, affecting relaxivity, biodistribution, and ultimately, their effectiveness in magnetic resonance imaging (MRI). Binding, primarily to serum albumin, can enhance signal intensity, alter plasma clearance, and impact dosing considerations. Different GBCAs exhibit varying degrees of protein binding, which must be considered for optimal imaging and safety.
- Other names
- GBCA Protein InteractionsGadolinium Contrast Agent BindingContrast Agent-Albumin Binding
02
Mechanism of action
N/A
03
Biological functions
MRI Contrast EnhancementPharmacokineticsDrug DistributionRelaxivity Modulation
04
Disease associations
Diagnostic ImagingCentral Nervous System Lesion DetectionTumor ImagingCardiovascular Imaging
05
Safety considerations
Gadolinium DepositionToxicokinetics VariationsConcentration Determination Challenges
06
Interacting drugs
Gadobenate dimeglumine
4 more in the full profile.
Beyond the preview
Go deeper on Gadolinium-Based Contrast Agents (GBCAs) - Protein Binding (GBCA Protein Binding).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gadolinium-Based Contrast Agents (GBCAs) - Protein Binding (GBCA Protein Binding).